In the high-risk group, 87.06% of (222/255) HNSCC cases had somatic mutations, with TTN, TP53, and MUC16 showing the highest frequency of alterations (Supplementary Figure S7A). The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.